|
|
||||||||
Ann Thorac Surg 1993;55:986-989
© 1993 The Society of Thoracic Surgeons
a Departments of Surgical Oncology, Medical Oncology, and Radiation Oncology, Fox Chase Cancer Center USA
b Temple University School of Medicine USA
c University of Pennsylvania, Philadelphia, Pennsylvania USA
Accepted for publication September 30, 1992.
* Address reprint requests to Dr Keller, Department of Cardiothoracic Surgery. The Mount Sinai Medical Center, 1 Gustave Levy Place, New-York, NY 10029.
Preoperative chemotherapy and radiation administered separately or in combination have been used in the treatment of locally advanced non-small cell lung cancer. To assess the postoperative morbidity and mortality associated with aggressive neoadjuvant therapy, we reviewed the records of 13 patients who underwent resection of locally advanced non-small cell lung cancer after two monthly cycles of infusional 5-fluorouracil, 640 to 800 mg/m2 (days 1 through 5); cisplatin, 20 mg/m2 (days 1 through 5); eloposide, 50 mg/m2 (days 1, 3, and 5); and concomitant radical thoracic irradiation (6,000 cGy) administered in 200-cGy daily fractions. Six patients underwent lobectomy with no mortality, whereas 7 pneumonectomies were associated with three deaths (43%). Culture-negative, diffuse pulmonary infiltrates developed 3 to 6 days after operation in 5 of 7 pneumonectomy patients and in 1 of 6 lobectomy patients. Two patients who had undergone pneumonectomy died of progressive adult respiratory distress syndrome. A third death resulted from a bronchopleural fistula that developed 30 days after pneumonectomy. Morbidity and mortality were not associated with preoperative pulmonary function test results, nutritional status, or intraoperative inspired oxygen fraction (p > 0.05 by
2 test). Only pneumonectomy correlated with increased morbidity and mortality (p < 0.05 by
2 test). We conclude that lobectomy may be performed safely after this combination of aggressive chemotherapy and high-dose radiation, but pneumonectomy is associated with unacceptable morbidity and mortality.
This article has been cited by other articles:
![]() |
V. Steger, W. Spengler, J. Hetzel, S. Veit, T. Walker, M. Mustafi, G. Friedel, and T. Walles Pneumonectomy: calculable or non-tolerable risk factor in trimodal therapy for Stage III non-small-cell lung cancer? Eur J Cardiothorac Surg, January 10, 2012; (2012) ezr160v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shien, M. Yamashita, M. Okazaki, H. Suehisa, S. Sawada, and S. Miyoshi Primary lung cancer surgery after curative chemoradiotherapy for esophageal cancer patients Interact CardioVasc Thorac Surg, June 1, 2011; 12(6): 1002 - 1006. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Saito, Y. Minamiya, H. Nanjo, M. Ito, T. Ono, S. Motoyama, M. Hashimoto, and J.-i. Ogawa Pathological finding of subclinical interstitial pneumonia as a predictor of postoperative acute respiratory distress syndrome after pulmonary resection Eur J Cardiothorac Surg, February 1, 2011; 39(2): 190 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Alloubi, J. Jougon, F. Delcambre, J. M. Baste, and J. F. Velly Early complications after pneumonectomy: retrospective study of 168 patients Interact CardioVasc Thorac Surg, August 1, 2010; 11(2): 162 - 165. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Weder, S. Collaud, W. E. E. Eberhardt, S. Hillinger, S. Welter, R. Stahel, and G. Stamatis Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancer J. Thorac. Cardiovasc. Surg., June 1, 2010; 139(6): 1424 - 1430. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Refai, A. Brunelli, G. Rocco, M. K. Ferguson, S. N. Fortiparri, M. Salati, A. La Rocca, and K. Kawamukai Does induction treatment increase the risk of morbidity and mortality after pneumonectomy? A multicentre case-matched analysis Eur J Cardiothorac Surg, March 1, 2010; 37(3): 535 - 539. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Krasna, Z. Gamliel, W. M. Burrows, J. R. Sonett, K. F. Kwong, M. J. Edelman, P. F. Hausner, L. A. Doyle, C. DeYoung, and M. Suntharalingam Pneumonectomy for Lung Cancer After Preoperative Concurrent Chemotherapy and High-Dose Radiation Ann. Thorac. Surg., January 1, 2010; 89(1): 200 - 206. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. d'Amato, A. S. Ashrafi, M. J. Schuchert, D. S.A. Alshehab, A. J.E. Seely, F. M. Shamji, D. E. Maziak, S. R. Sundaresan, P. F. Ferson, J. D. Luketich, et al. Risk of Pneumonectomy After Induction Therapy for Locally Advanced Non-Small Cell Lung Cancer Ann. Thorac. Surg., October 1, 2009; 88(4): 1079 - 1085. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Cerfolio, A. Talati, and A. S. Bryant Changes in Pulmonary Function Tests After Neoadjuvant Therapy Predict Postoperative Complications Ann. Thorac. Surg., September 1, 2009; 88(3): 930 - 936. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Steger, T. Walles, B. Kosan, T. Walker, T. Kyriss, S. Veit, J. Dippon, and G. Friedel Trimodal Therapy for Histologically Proven N2/3 Non-Small Cell Lung Cancer: Mid-Term Results and Indicators for Survival Ann. Thorac. Surg., June 1, 2009; 87(6): 1676 - 1683. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Cerfolio, A. S. Bryant, V. L. Jones, and R. M. Cerfolio Pulmonary resection after concurrent chemotherapy and high dose (60 Gy) radiation for non-small cell lung cancer is safe and may provide increased survival Eur J Cardiothorac Surg, April 1, 2009; 35(4): 718 - 723. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Bauman, M. S. Mulligan, R. G. Martins, B. F. Kurland, K. D. Eaton, and D. E. Wood Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes Ann. Thorac. Surg., November 1, 2008; 86(5): 1632 - 1639. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Yildizeli, P. G. Dartevelle, E. Fadel, S. Mussot, and A. Chapelier Results of Primary Surgery With T4 Non-Small Cell Lung Cancer During a 25-Year Period in a Single Center: The Benefit is Worth the Risk Ann. Thorac. Surg., October 1, 2008; 86(4): 1065 - 1075. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Gudbjartsson, E. Gyllstedt, A. Pikwer, and P. Jonsson Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy Ann. Thorac. Surg., August 1, 2008; 86(2): 376 - 382. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Alifano, M. S. Boudaya, M. Salvi, J.-Y. Collet, C. Dinu, S. Camilleri-Broet, and J.-F. Regnard Pneumonectomy After Chemotherapy: Morbidity, Mortality, and Long-Term Outcome Ann. Thorac. Surg., June 1, 2008; 85(6): 1866 - 1873. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yokomise, M. Gotoh, T. Okamoto, Y. Yamamoto, S. Ishikawa, T. Nakashima, D. Masuya, D. Liu, and C.-l. Huang Induction chemoradiotherapy (carboplatin-taxane and concurrent 50-Gy radiation) for bulky cN2, N3 non small cell lung cancer J. Thorac. Cardiovasc. Surg., May 1, 2007; 133(5): 1179 - 1185. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Venuta, M. Anile, D. Diso, M. Ibrahim, T. De Giacomo, M. Rolla, V. Liparulo, and G. F. Coloni Operative complications and early mortality after induction therapy for lung cancer Eur J Cardiothorac Surg, April 1, 2007; 31(4): 714 - 718. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Mansour, E. A. Kochetkova, X. Ducrocq, M.-D. Vasilescu, G. Maxant, A. Buggenhout, J.-M. Wihlm, and G. Massard Induction chemotherapy does not increase the operative risk of pneumonectomy! Eur J Cardiothorac Surg, February 1, 2007; 31(2): 181 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Kuzniar, M. G. Blum, K. Kasibowska-Kuzniar, and G. M. Mutlu Predictors of Acute Lung Injury and Severe Hypoxemia in Patients Undergoing Operative Talc Pleurodesis Ann. Thorac. Surg., December 1, 2006; 82(6): 1976 - 1981. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Maniwa, Y. Saito, H. Kaneda, and H. Imamura Bronchial stump reinforcement with the intercostal muscle flap without adverse effects Eur J Cardiothorac Surg, October 1, 2006; 30(4): 652 - 656. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D.T. Daly, H. C. Fernando, A. Ketchedjian, T. A. DiPetrillo, L. A. Kachnic, D. M. Morelli, and R. J. Shemin Pneumonectomy After High-Dose Radiation and Concurrent Chemotherapy for Nonsmall Cell Lung Cancer Ann. Thorac. Surg., July 1, 2006; 82(1): 227 - 231. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-i. Takeda, Y. Funakoshi, Y. Kadota, M. Koma, H. Maeda, S. Kawamura, and Y. Matsubara Fall in Diffusing Capacity Associated With Induction Therapy for Lung Cancer: A Predictor of Postoperative Complication? Ann. Thorac. Surg., July 1, 2006; 82(1): 232 - 236. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dulu, S. M. Pastores, B. Park, E. Riedel, V. Rusch, and N. A. Halpern Prevalence and Mortality of Acute Lung Injury and ARDS After Lung Resection Chest, July 1, 2006; 130(1): 73 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fujita, N. Katakami, Y. Takahashi, K. Hirokawa, A. Ikeda, C. Tabata, T. Mio, and M. Mishima Postoperative complications after induction chemoradiotherapy in patients with non-small-cell lung cancer Eur J Cardiothorac Surg, June 1, 2006; 29(6): 896 - 901. [Full Text] [PDF] |
||||
![]() |
Y. Matsubara, S.-i. Takeda, and T. Mashimo Risk Stratification for Lung Cancer Surgery: Impact of Induction Therapy and Extended Resection Chest, November 1, 2005; 128(5): 3519 - 3525. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Cerfolio, A. S. Bryant, S. A. Spencer, and A. A. Bartolucci Pulmonary Resection After High-Dose and Low-Dose Chest Irradiation Ann. Thorac. Surg., October 1, 2005; 80(4): 1224 - 1230. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Van Schil, J. Van Meerbeeck, G. Kramer, T. Splinter, C. Legrand, G. Giaccone, C. Manegold, and N. van Zandwijk Morbidity and mortality in the surgery arm of EORTC 08941 trial Eur. Respir. J., August 1, 2005; 26(2): 192 - 197. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Doddoli, F. Barlesi, D. Trousse, S. Robitail, S. Yena, P. Astoul, R. Giudicelli, P. Fuentes, and P. Thomas One hundred consecutive pneumonectomies after induction therapy for non-small cell lung cancer: An uncertain balance between risks and benefits J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 416 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Semik, D. Riesenbeck, A. Linder, C. Schmid, P. Hoffknecht, A. Heinecke, H. H. Scheld, M. Thomas, and for The German Lung Cancer Cooperative Group Preoperative chemotherapy with and without additional radiochemotherapy: benefit and risk for surgery of stage III non-small cell lung cancer Eur J Cardiothorac Surg, December 1, 2004; 26(6): 1205 - 1210. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lucchi, P. Dini, F. Givigliano, A. Ribechini, and A. Mussi Massive pneumoencephalus of late onset after an en bloc resection for lung cancer J. Thorac. Cardiovasc. Surg., June 1, 2004; 127(6): 1836 - 1838. [Full Text] [PDF] |
||||
![]() |
K. L. Greason, D. L. Miller, R. P. Clay, C. Deschamps, C. H. Johnson, M. S. Allen, V. F. Trastek, and P. C. Pairolero Management of the irradiated bronchus after lobectomy for lung cancer Ann. Thorac. Surg., July 1, 2003; 76(1): 180 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Betticher, S.-F. Hsu Schmitz, M. Totsch, E. Hansen, C. Joss, C. von Briel, R. A. Schmid, M. Pless, J. Habicht, A. D. Roth, et al. Mediastinal Lymph Node Clearance After Docetaxel-Cisplatin Neoadjuvant Chemotherapy Is Prognostic of Survival in Patients With Stage IIIA pN2 Non-Small-Cell Lung Cancer: A Multicenter Phase II Trial J. Clin. Oncol., May 1, 2003; 21(9): 1752 - 1759. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Miller, C. Deschamps, G. D. Jenkins, A. Bernard, M. S. Allen, and P. C. Pairolero Completion pneumonectomy: factors affecting operative mortality and cardiopulmonary morbidity Ann. Thorac. Surg., September 1, 2002; 74(3): 876 - 884. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Stamatis, D. Djuric, W. Eberhardt, C. PottkenPottken, G. Zaboura, S. Fechner, and T. Fujimoto Postoperative morbidity and mortality after induction chemoradiotherapy for locally advanced lung cancer: an analysis of 350 operated patients Eur J Cardiothorac Surg, August 1, 2002; 22(2): 292 - 297. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.P. van Meerbeeck, R.A.M. Damhuis, and M.L. Vos de Wael High postoperative risk after pneumonectomy in elderly patients with right-sided lung cancer Eur. Respir. J., January 1, 2002; 19(1): 141 - 145. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Komaki, M. H. Chasen, W. D. Travis, J. B. Putnam, F. V. Fossella, R. W. Byhardt, and J. Y. Ro Oncodiagnosis Panel: 1999: Cancer of the Lung: Oncodiagnosis RadioGraphics, November 1, 2001; 21(6): 1573 - 1596. [Full Text] [PDF] |
||||
![]() |
J. Martin, R. J. Ginsberg, A. Abolhoda, M. S. Bains, R. J. Downey, R. J. Korst, T. L. Weigel, M. G. Kris, E. S. Venkatraman, and V. W. Rusch Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy Ann. Thorac. Surg., October 1, 2001; 72(4): 1149 - 1154. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Novoa, G. Varela, and M. F. Jimenez Morbidity after surgery for non-small cell lung carcinoma is not related to neoadjuvant chemotherapy Eur J Cardiothorac Surg, October 1, 2001; 20(4): 700 - 704. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Doddoli, P. Thomas, X. Thirion, Y. Seree, R. Giudicelli, and P. Fuentes Postoperative complications in relation with induction therapy for lung cancer Eur J Cardiothorac Surg, August 1, 2001; 20(2): 385 - 390. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ruffini, A. Parola, E. Papalia, P. L. Filosso, M. Mancuso, A. Oliaro, G. Actis-Dato, and G. Maggi Frequency and mortality of acute lung injury and acute respiratory distress syndrome after pulmonary resection for bronchogenic carcinoma Eur J Cardiothorac Surg, July 1, 2001; 20(1): 30 - 37. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Siegenthaler, K. M. Pisters, K. W. Merriman, J. A. Roth, S. G. Swisher, G. L. Walsh, A. A. Vaporciyan, W. R. Smythe, and J. B. Putnam Jr Preoperative chemotherapy for lung cancer does not increase surgical morbidity Ann. Thorac. Surg., April 1, 2001; 71(4): 1105 - 1112. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Yamamoto, H. Tada, A. Kishi, and T. Tojo Effects of preoperative chemotherapy and radiation therapy on human bronchial blood flow J. Thorac. Cardiovasc. Surg., May 1, 2000; 119(5): 939 - 945. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Kutlu, E. A. Williams, T. W. Evans, U. Pastorino, and P. Goldstraw Acute lung injury and acute respiratory distress syndrome after pulmonary resection Ann. Thorac. Surg., February 1, 2000; 69(2): 376 - 380. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Stamatis, W. Eberhardt, G. Stuben, S. Bildat, O. Dahler, and L. Hillejan Preoperative chemoradiotherapy and surgery for selected non-small cell lung cancer IIIB subgroups: long-term results Ann. Thorac. Surg., October 1, 1999; 68(4): 1144 - 1149. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Sonett, M. J. Krasna, M. Suntharalingam, J. Schuetz, L. A. Doyle, R. Lilenbaum, and Z. Gamliel Safe pulmonary resection after chemotherapy and high-dose thoracic radiation Ann. Thorac. Surg., August 1, 1999; 68(2): 316 - 320. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Thomas, C. Rube, M. Semik, M. von Eiff, L. Freitag, H. N. Macha, W. Wagner, F. Klinke, H. H. Scheld, N. Willich, et al. Impact of Preoperative Bimodality Induction Including Twice-Daily Radiation on Tumor Regression and Survival in Stage III Non-Small-Cell Lung Cancer J. Clin. Oncol., April 1, 1999; 17(4): 1185 - 1185. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Klepetko, W. Wisser, T. Birsan, P. Mares, S. Taghavi, N. Kupilik, and E. Wolner T4 lung tumors with infiltration of the thoracic aorta: is an operation reasonable? Ann. Thorac. Surg., February 1, 1999; 67(2): 340 - 344. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Rendina, F. Venuta, T. D. Giacomo, A. M. Ciccone, G. Ruvolo, G. F. Coloni, C. Ricci, and S. G. A. Patterson INDUCTION CHEMOTHERAPY FOR T4 CENTRALLY LOCATED NON-SMALL CELL LUNG CANCER J. Thorac. Cardiovasc. Surg., February 1, 1999; 117(2): 225 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Rendina, F. Venuta, T. De Giacomo, I. Flaishman, P. Fazi, C. Ricci, Sponsor:, and V. W. Rusch SAFETY AND EFFICACY OF BRONCHOVASCULAR RECONSTRUCTION AFTER INDUCTION CHEMOTHERAPY FOR LUNG CANCER J. Thorac. Cardiovasc. Surg., November 1, 1997; 114(5): 830 - 837. [Abstract] [Full Text] |
||||
![]() |
J. L. Duque, G. Ramos, J. Castrodeza, J. Cerezal, M. Castanedo, M. G. Yuste, and F. Heras Early Complications in Surgical Treatment of Lung Cancer: A Prospective, Multicenter Study Ann. Thorac. Surg., April 1, 1997; 63(4): 944 - 950. [Abstract] [Full Text] |
||||
![]() |
V. W. Rusch and J. R. Benfield Neoadjuvant therapy for lung cancer: A note of caution Ann. Thorac. Surg., April 1, 1993; 55(4): 820 - 821. [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |